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Edited by Gianni CesareniAbstract The ankyrin repeat and SOCS box (ASB) family is
composed of 18 proteins from ASB1 to ASB18 and belongs to
the suppressor of cytokine signaling (SOCS) box protein super-
family. ASB2 was recently shown to interact with a certain
Cul–Rbx module to form an E3 ubiquitin (Ub) ligase complex,
but the functional composition of the ASB-containing E3 Ub li-
gase complexes remains to be characterized. Here, we show that
ASB proteins interact with Cul5–Rbx2 but neither Cul2 nor
Rbx1 in cells. Mutational analysis revealed that the highly con-
served amino acid sequences of the BC box and Cul5 box in the
SOCS box of ASB proteins were essential for the interaction with
Cul5–Rbx2. Although ASB proteins show slight divergences from
the consensus sequences of the BC box and Cul5 box, all ﬁve
tested ASB proteins bound to Cul5–Rbx2. Furthermore, all three
tested ASB complexes containing Cul5–Rbx2 were found to have
E3 Ub ligase activity. These ﬁndings suggest that the ASB family
proteins interact with Cul5–Rbx2 to form E3 Ub ligases and play
signiﬁcant roles via a ubiquitination-mediated pathway.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The ubiquitin (Ub)-proteasome system is the major pathway
of non-lysosomal degradation of various cellular proteins in-
volved in cell cycle progression and signal transduction cas-
cade [1,2]. In this pathway, Ub covalently binds to the target
proteins, thereby allowing proteolytic degradation by the 26S
proteasome. The ubiquitination involves a series of multien-
zymes, i.e., Ub-activating enzyme (E1), Ub-conjugating en-
zyme (E2) and Ub ligase (E3) [3]. There are a large number
of E3 Ub ligases, which are classiﬁed into three families,Abbreviations: SOCS, suppressor of cytokine signaling; ASB, ankyrin
repeat and SOCS box; Cul, Cullin; DTT, dithiothreitol; EDTA, eth-
ylenediaminetetraacetic acid; GST, glutathione-S-transferase; HRP,
horseradish peroxidase; IPTG, isopropyl-b-D()-thiogalactopyrano-
side; PBS, phosphate-buﬀered saline; PVDF, polyvinylidene diﬂuoride;
SCF, Skp1/Cullin/F-box protein complex; SDS–PAGE, sodium dode-
cyl sulfate–polyacrylamide-gel electrophoresis; TBST, Tris-buﬀered
saline with Tween 20; Ub, ubiquitin; pVHL, von Hippel–Lindau dis-
ease protein; APS, adaptor protein containing PH and SH2 domains
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tional domains. Each E3 Ub ligase recognizes its target protein
and catalyzes the formation of isopeptide bonds between the
C-terminal glycine of Ub and the e-NH2 groups of lysine res-
idues in the target protein [4]. The speciﬁcities for ubiquitina-
tion and degradation of the substrate are determined by each
E3 Ub ligase. Thus, E3 Ub ligases are key molecules in the reg-
ulation of Ub-dependent proteolysis.
Some E3 Ub ligases function as a multi-subunit complex
composed of a substrate-recognition protein such as a suppres-
sor of cytokine signaling (SOCS) box-containing protein, a plat-
form protein called Cullin (Cul), a RING family protein called
Rbx and an adapter protein such as skp1 or elongin B/C com-
plex [5]. In mammals, two Rbx proteins, Rbx1 and Rbx2, and
numerous Cul proteins such as Cul1, Cul2, Cul3, Cul4A,
Cul4B, Cul5, Cul7 and Parc have been identiﬁed [6]. Rbx binds
to the C-terminus of Cul, which then binds to an adapter pro-
tein at the N-terminus. One pivotal function of Rbx is to recruit
E2 Ub-conjugating enzyme into the E3 complex.
It has been known that some SOCS box-containing proteins
work as a substrate-recognition component of E3 Ub ligase
complex [7]. SOCS box proteins commonly contain two func-
tional protein–protein interaction domains, i.e., an SOCS box
domain and a substrate-binding domain. The SOCS box con-
sists of approximately 40 amino acids located at the C-terminus
of the protein. The SOCS box is divided into two sub-domains,
BC box and Cul2/Cul5 box [8]. Based on the structural diﬀer-
ences in their substrate-binding domains, the SOCS box protein
superfamily is composed of the SOCS family containing a SH2
domain, von Hippel–Lindau disease protein (pVHL) contain-
ing a b-domain, the ankyrin repeat and SOCS box (ASB) family
containing an ankyrin repeat, WSB1 and WSB2 containing a
WD40 repeat and the SSB family containing a SPRY domain
[7]. It has been shown that SOCS1 and/or SOCS3 bind to
JAK1 [9], JAK2 [9], TEL-JAK2 [10,11], Vav [12], IRS1 [13]
or IRS2 [13] for ubiquitination. pVHL, another SOCS box pro-
tein, binds to and ubiquitinates HIF1-a, a transcriptional fac-
tor that induces numerous hypoxia-inducible genes during
angiogenesis [14,15].
Little is known about the function of the ASB family as a
substrate-recognition component of multi-subunit E3 Ub li-
gase, although some interesting observations have been re-
ported [16,17]. We demonstrated that expression of the gene
for ASB2, a member of the ASB family, was signiﬁcantly in-
creased by stimulation of human myeloid leukemia cells with
all-trans retinoic acid (ATRA) [16], and the ﬁnding was also
reported by others [17]. The fact that the ASB2 gene expression
of those cells in response to ATRA was accompanied byblished by Elsevier B.V. All rights reserved.
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biological function of ASB2 might lead to degradation of spe-
ciﬁc proteins involved in cell proliferation or signal transduc-
tion. Wilcox et al. found by yeast two-hybrid screening that
interaction of ASB6 with adaptor protein containing PH and
SH2 domains (APS) was involved in signaling of insulin recep-
tor and insulin-like growth factor receptor and that ASB6
facilitated the decrease in the APS protein level in response
to stimulation with insulin [18]. It was also demonstrated that
ASB3 bound to TNF receptor II (TNF-R2), resulting in ubiq-
uitination and proteasomal degradation of TNF-R2 [19].
These ﬁndings suggest that ASB2 also might participate in
ubiquitination and degradation of the proteins involved in
receptor signaling.
Recently, it was reported that SOCS-3, WSB1 and SSB1–4
formed E3 Ub ligase complexes with Cul5 and Rbx2, whereas
pVHL formed complexes with Cul2 and Rbx1 [20]. These com-
plexes functioned as E3 Ub ligases to degrade their respective
target proteins. However, the E3 Ub ligase complexes of the
ASB family remain to be characterized. Thus, in this study,
we investigated what kinds of Cul–Rbx modules ASB proteins
interact with to form E3 Ub ligase complexes in vivo.2. Materials and methods
2.1. Antibodies
Antibodies were purchased from the following companies: mouse
monoclonal antibody to FLAG (M2) from Sigma–Aldrich Co. (St.
Louis, MO); rabbit polyclonal antibody to Cul5 (H-300) and goat
polyclonal antibody to Rbx2 (N-15) from Santa Cruz Biotechnology
(Santa Cruz, CA); rabbit polyclonal antibody to Rbx1 from Lab Vi-
sion/Neomaker (Freemont, CA); rabbit polyclonal antibody to Cul2
from Zymed Laboratories (San Francisco, CA); goat polyclonal anti-
body to glutathione-S-transferase (GST) from Bethyl Laboratories
(Montgomery, TX); and horseradish peroxidase (HRP)-conjugated
goat polyclonal antibodies to mouse and rabbit Igs and HRP-conju-
gated swine polyclonal antibodies to goat Igs from Biosource Interna-
tional (Camarillo, CA).
2.2. Plasmid constructions
Human full-length cDNAs encoding ASB1, ASB2, ASB6, ASB7,
ASB12 and pVHL, and truncated mutant of ASB2 (ASB2DC), which
lacks 539–587 amino acids, were ampliﬁed by PCR with the following
primers: forward, 5 0-GCGGAAGAATTCATGGCGGAGGGCGGC-
AGCCCAGA-3 0 and reverse, 5 0-CTTGGGCGGCCGCGCTCATG-
GAGTAGAAACTTCTT-3 0 for ASB1; forward, 5 0-TTCCTGCCT-
GAATTCATGACCCGCTTCTCC-3 0 and reverse, 5 0-CGTGGGCG-
GCCGCACTGGGTGTTCTCGTATTTCAGGTA-3 0 for ASB2;
forward, 5 0-GGCCCGAATTCATGCCGTTCCTGCACGGCTT-3 0
and reverse, 5 0-GCCTGAGCGGCCGCGGATGTCATCTTCCACG-
GAGC-3 0 for ASB6; forward, 5 0-GACTCAGAATTCATGTTACA-
CCATCATTGTCGAAG-3 0 and reverse, 5 0-TCGACGCGGCCGCG-
GATATCATCAAATTTGTGTTT-3 0 for ASB7; forward, 5 0-
GCATGCGAATTCATGAACCTCATGGACATCACCA-3 0 and
reverse, 5 0-TCGACGCGGCCGCGCAGTTGGTGTTTTAGGTAG-
CT-30 for ASB12; forward, 5 0-ATCGTTAGAATTCGGAATGCC-
CCGGAGGGCGGAGA-3 0 and reverse, 5 0-TAACGATGGATCC-
ATCTCCCATCCGTTGATGT-30 for pVHL; forward, 5 0-TTCCTG-
CCTGAATTCATGACCCGCTTCTCC-3 0 and reverse, 5 0-TTCTGC-
GCGGCCGCTGATGACGGCCCA-30 for ASB2DC. The restriction
sites are indicated by underlining. The cDNA products were digested
with EcoRI and NotI, except for pVHL, which was digested with
EcoRI and BamHI. The multi-cloning site of C-terminal 3 · FLAG-
tagged protein expression plasmid p3 · FLAG-CMV-14 (Sigma–Al-
drich Co.) was modiﬁed by insertion of the following double-strand
oligonucleotides at the HindIII–KpnI site, generating a NotI site in
addition to the original sites: sense, 5 0-AGCTTGAATTCGTC-
CGCGGCCGCGTCGAGGTAC-3 0 and antisense, 5 0-GTCGAC-GCGGCCGCGGACGAATTCA-3 0 (EcoRIandNotI sitesare indicated
by underlining). The digested cDNA fragments of ASB genes were in-
serted into a modiﬁed p3 · FLAG-CMV-14 vector at the EcoRI–NotI
site and the pVHL gene fragment at the EcoRI–BamHI site. Two ASB
mutants, ASB2M1 and ASB2M2, were generated by site-directed
mutagenesis. Brieﬂy, the template p3 · FLAG-CMV-14-ASB2 was
ampliﬁed by PCR using the following primers: forward, 5 0-CC-
TCTGGCTCACCCTTTCCGACTGCGGGTTCGA-3 0 and reverse,
5 0-AACCCGCAGTCGGAAAGGGTGAGCCAGAGGTCT-3 0 for
ASB2-M1; forward, 5 0-CCTAGACACCGCGGCGGCCGCAGGC-
AGGCTGATTA-3 0 and reverse, 5 0-AGCCTGCCTGCGGCCGCC-
GCGGTGTCTAGGAGTTT-3 0 for ASB2-M2. The cDNA products
were digested with DpnI and introduced into Escherichia coli DH5a-
competent cells. The cDNA encoding a single molecule of Ub was
ampliﬁed by PCR using the following primers: forward, 5 0-CCCGA-
GGATCCATGCAGATCTTCGTGAAGAC-3 0 andreverse,5 0-CCCG-
CGAATTCGTCTTCACGAAGATCTGCTAAC-30 (restriction sites
are underlined). The cDNA product was digested with BamHI and
EcoRI and subcloned into pGEX-2TK (Amersham Biosciences, Pis-
cataway, NJ) at the EcoRI–BamHI site. All constructed plasmids were
veriﬁed by sequencing. The plasmid for bacterial expression of N-ter-
minal 6 ·His-tagged human E2 Ub-conjugating enzymes, pT7-7-
(His)6-Ubc5a, was kindly provided by Professor Kazuhiro Iwai
(Osaka City University).
2.3. Cell culture and transfection
HEK293 cells were grown in Dulbeccos modiﬁed Eagles medium
(Sigma–Aldrich Co.) in the presence of 10% heat-inactivated fetal bov-
ine serum, 1000 U/ml of penicillin and 1 mg/ml of streptomycin (Sigma–
Aldrich Co.) at 37 C and 5% CO2. HEK293 cells grown in dishes (60
or 100 mm diameter) were transfected using TransFast transfection re-
agent (Promega,Madison,WI) according to the manufacturers instruc-
tions and harvested 24 h after transfection. The amounts of DNA used
for transfection were 0.2 lg for 60-mm and 0.5 lg for 100-mm diameter
plates.
2.4. Immunoprecipitation
HEK293 cells thus transfected with diﬀerent expression vectors in a
60-mm-diameter plate were harvested and washed twice with ice-cold
phosphate-buﬀered saline (PBS) (8.1 mM Na2HPO4, 1.5 mM
KH2PO4, 0.137 M NaCl and 2.7 mM KCl; pH 7.2). Cells were lysed
on ice for 30 min in 0.5 ml of lysis buﬀer containing 50 mM Tris–
HCl (pH 7.5), 150 mM NaCl, 1 mM ethylenediaminetetraacetic acid
(EDTA), 0.5% Nonidet P-40 and 1 mM dithiothreitol (DTT). The
resulting cell extracts were clariﬁed by centrifugation at 14000 · g
for 30 min at 4 C, mixed with 10 ll of anti-FLAGM2 aﬃnity agarose
beads (Sigma–Aldrich Co.) and then incubated for 1 h at 4 C. The
beads containing immunocomplexes were washed four times with the
lysis buﬀer, and then the bound proteins were eluted with 20 ll of
3 · FLAG peptide at 0.2 lg/ll.
2.5. Immunoblotting
Proteins were separated by sodium dodecyl sulfate–polyacrylamide-
gel electrophoresis (SDS–PAGE) and transferred to polyvinylidene
diﬂuoride (PVDF) membranes (Pall Corporation, Ann Arbor, MI).
The membranes were blocked with 5% non-fat dry milk in Tris-buﬀered
saline with Tween 20 (TBST) (50 mM Tris–HCl (pH 7.5) containing
150 mM NaCl and 0.2% Tween 20) for 2 h at room temperature, alter-
natively overnight at 4 C, and then probedwith the antibodies indicated
in the ﬁgures for 2 h at room temperature, alternatively overnight at
4 C. After washing with TBST, the membranes were probed with
appropriate secondary antibodies conjugated with HRP for 1 h at room
temperature, and then washed with TBST again. The membranes were
treated with ECL Western blotting detection reagents (Amersham Bio-
sciences) according to the manufacturers instructions, and detected
bands were exposed to X-ray ﬁlms (Kodak Co., Rochester, NY).
2.6. Expression of recombinant proteins in Escherichia coli
Escherichia coli BL21kDE3-competent cells were transformed with
pGEX-2TK-ubiquitin or pT7-7(His)6-Ubc5a and grown in 1 L
of 2 · YT medium in the presence of 100 lg/ml of ampicillin at
30 C. Production of the recombinant protein, i.e., GST-Ub or
6 ·His-Ubc5a, was induced with 0.4 mM isopropyl-b-D()-thiogalac-
topyranoside (IPTG) for 2 h. The cells were resuspended on ice with
Fig. 1. Interaction of ASB2 with Cul5–Rbx2. HEK293 cells were
transiently transfected with the indicated 3 · FLAG-tagged expression
vectors. After 24 h, the cells were lysed, and the cell extracts were
subjected to immunoprecipitation with anti-FLAG antibody. The
resulting immunoprecipitates were eluted with 3 · FLAG peptide,
separated by SDS–PAGE and immunoblotted with four distinct
antibodies speciﬁc for Cul2, Cul5, Rbx1 and Rbx2.
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cocktail (Sigma–Aldrich Co.) and then lysed by sonication. The resul-
tant solutions were centrifuged at 10000 · g for 15 min at 4 C. For
puriﬁcation of GST-Ub, the supernatant was applied to a glutathione
Sepharose 4B column (Amersham Biosciences). The column was
washed with PBS containing 1 mM DTT, and the bound protein was
eluted with 0.1 M Tris-HCl (pH 8.0) containing 0.12 M NaCl and
20 mM reduced glutathione. After dialysis against 40 mMHEPES buf-
fer (pH 7.9) containing 60 mM CH3COOK, 5 mM MgCl2, 0.5 mM
EDTA, 1 mM DTT and 10% glycerol, the puriﬁed protein was stored
at 80 C. For puriﬁcation of 6 · His-Ubc5a, the supernatant after
centrifugation was applied to a Ni-NTA agarose column (Invitrogen,
Carlsbad, CA). The column was washed with wash buﬀer composed
of 50 mM Na phosphate buﬀer (pH 8.0) containing 0.5 M NaCl and
20 mM imidazole, and then the bound protein was eluted with elution
buﬀer composed of 50 mM Na phosphate buﬀer (pH 8.0) containing
0.5 M NaCl and 250 mM imidazole. After dialysis against 40 mM
HEPES buﬀer (pH 7.9) containing 60 mM CH3COOK, 5 mM MgCl2,
0.5 mM EDTA, 1 mMDTT and 10% glycerol, the puriﬁed protein was
stored at 80 C.
2.7. In vitro ubiquitination assay
The cell extracts of HEK293 cells (10-mm-diameter plate) transfec-
ted with p3 · FLAG-ASBs, prepared as described above, were precip-
itated with 4.9 lg of anti-FLAG antibody (M2) and 10 ll of protein G
agarose beads (Santa Cruz Biotechnology) for 1 h at 4 C. The beads
were washed three times with lysis buﬀer composed of 50 mM Tris–
HCl (pH 7.5), 0.15 M NaCl, 1 mM EDTA, 0.5% Nonidet P-40 and
1 mM DTT and then twice with 40 mM HEPES buﬀer (pH 7.9) con-
taining 60 mM CH3COOK, 1 mM MgCl2, 0.5 mM EDTA, 2 mM
DTT and 10% glycerol. The resulting immunocomplexes were mixed
with 500 ng of mouse Uba1 (Wako Pure Chemical Industries Ltd.,
Osaka, Japan), 1.5 lg of 6 ·His-UbcH5a and 2.5 ng of GST-Ub in
20 ll of 40 mM HEPES buﬀer (pH 7.9) containing 60 mM
CH3COOK, 5 mM MgCl2, 1 mM DTT and 1.5 mM ATP. The reac-
tion mixtures were incubated for 1 h at 37 C, and the resulting protein
products were separated by SDS–PAGE and subjected to immuno-
blotting with anti-GST antibody and HRP-conjugated secondary anti-
body to goat Igs.3. Results
3.1. ASB2 interacts with Cul5 and Rbx2
To identify the proteins that interact with ASB2, we ﬁrst
constructed a 3 · FLAG-fused ASB2 expression vector and ex-
pressed it in HEK293 cells. The proteins interacting with ASB2
were immunoprecipitated with anti-FLAG antibody and pro-
tein G agarose gels. It is well known that elongin B/C adapter
proteins associate with SOCS box proteins and Cul–Rbx mod-
ules to form complexes of elongin B/C, SOCS box protein and
Cul–Rbx [20,21]. Thus, the proteins that bound to the gels
were subjected to immunoblotting with four diﬀerent antibod-
ies speciﬁc for Cul2, Cul5, Rbx1 and Rbx2. The immunoblot
analysis revealed that endogenously expressed Cul5 and
Rbx2, but not either Cul2 or Rbx1, were co-precipitated with
ASB2 (Fig. 1, lane 2). However, a deletion mutant of ASB2 or
ASB2DC that lacks SOCS box no longer co-precipitated with
Cul5 and Rbx2 (Fig. 1, lane 3). pVHL was used as the exper-
imental control because it is known to interact with Cul2 and
Rbx1 via elongin B/C [22]. pVHL clearly immunoprecipitated
Cul2 and Rbx1 but not Cul5 or Rbx2 (Fig. 1, lane 4). These
results suggest that ASB2 interacts with Cul5 and Rbx2
in vivo through its SOCS box domain.
Recently, it was proposed that the sequences located down-
stream of the BC box be classiﬁed into two groups, Cul2 box
and Cul5 box, on the basis of their sequence homology and
binding speciﬁcity for Cul2 or Cul5 [20]. All 18 ASB members
share the consensus sequences of BC box and Cul5 box in theirSOCS box, with only slight divergences (Fig. 2). In SOCS1,
SSB1, SSB4 and RAR3 molecules, both the BC box and Cul5
box were essential for interaction with Cul5–Rbx2. Thus, in
the ASB proteins, as well, the BC box and Cul5 box were antic-
ipated to be responsible for interaction with Cul5–Rbx2. To
investigate this, two distinct mutants of ASB2 were con-
structed. Mutant ASB2M1 had PF in place of LC in BC box,
and mutant ASB2M2 had AAAA instead of LPLP in Cul5
box (Fig. 3A). These mutant and wild-type ASB2 proteins were
expressed in HEK293 cells, and their abilities to interact with
endogenous Cul5 and Rbx2 were examined by immunoprecip-
itation and immunoblotting analysis. Although the two mu-
tants were expressed as much as the wild-type ASB2 in the
cells, neither ASB2M1 nor ASB2M2 co-precipitated any of
Cul2, Cul5, Rbx1 or Rbx2 (Fig. 3B). These results suggest that
the BC box and Cul5 box amino acid sequences shared by ASB
family proteins are essential for interaction with Cul5–Rbx2.
3.2. Not only ASB2 but also other ASB proteins interact with
Cul5–Rbx2
Interaction of ASB2 with Cul5–Rbx2 requires both amino
acid sequences of LC in its BC box and LPLP in its Cul5
box. Although these amino acid sequences are shared by
numerous SOCS box proteins, a few ASB proteins contain se-
quences diﬀerent from LC and LPLP (Fig. 2). For example,
the conserved LC in the BC box is replaced by LA in ASB8
and ASB16, LS in ASB4 and ASB10, and QV in ASB12.
Replacements of LC by LA or LS were also found in two
other SOCS box proteins, Vif and SSB2, respectively, and
these proteins were able to interact with Cul5 [20,23]. Replace-
ment of LC by QV was found only in ASB12. The ASB family
has some diversity in the Cul5 box as well. The LPLP motif is
Fig. 2. Amino acid sequence alignments of the SOCS box of ASB proteins. Identical and similar amino acids are indicated by black and gray
shading, respectively.
Fig. 3. Wild-type ASB2 and two ASB2 mutants having a mutation in the BC box or Cul5 box. (A) Schematic diagram of the ASB2 wild-type (WT)
and two mutants, ASB2M1 and ASB2M2. Amino acid sequences are shown as letters. Mutated amino acids are underlined. (B) Abilities of the ASB2
mutants to interact with Cul5 and Rbx2. HEK293 cells were transfected with the indicated 3 · FLAG-tagged expression vectors expressing wild-type
ASB2, mutant ASB2M1 or mutant ASB2M2. After 24 h, the cells were lysed, and the cell extracts were subjected to immunoprecipitation with anti-
FLAG antibody. The resulting immunoprecipitates were eluted with 3 · FLAG peptide, separated by SDS–PAGE and immunoblotted with anti-
Cul2, anti-Cul5, anti-Rbx1 or anti-Rbx2 antibody.
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Fig. 4. Interaction of ASB proteins with Cul5–Rbx2. HEK293 cells
were transfected with the indicated 3 · FLAG-tagged expression
vectors. After 24 h, the cells were lysed, and the cell extracts were
subjected to immunoprecipitation with anti-FLAG antibody. The
resulting immunoprecipitates were eluted with 3 · FLAG peptide,
separated by SDS–PAGE and immunoblotted with anti-Cul2, anti-
Cul5, anti-Rbx1, anti-Rbx2 or anti-FLAG antibody.
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Cul5 box, was reported not to interact with Cul5 or Rbx2
[20]. Thus, we next examined whether these ASB proteins with
sequences divergent from the consensus motifs retain the abil-
ity to associate with Cul–Rbx modules. ASB1, ASB6, ASB7
and ASB12 were immunoprecipitated, and the ASB-containing
complexes were subjected to immunoblotting. All the ASB
proteins tested here interacted with endogenously expressed
Cul5 and Rbx2, and none showed interaction with Cul2 or
Rbx1, unlike pVHL (Fig. 4). Therefore, the results suggest thatFig. 5. In vitro ubiquitination activities of ASB complexes. (A) HEK293 cell
ASB2 or ASB2M1. After 24 h, cell extracts were prepared and immunopreci
were incubated for 1 h at 37 C with or without E1 or E2 in the presence o
separated by SDS–PAGE and subjected to immunoblotting with anti-GST
expression vectors expressing ASB2, ASB1 or ASB12. After 24 h, cell extracts
ASB complexes were incubated for 1 h at 37 C with or without E1 and E2 i
mixture were separated by SDS–PAGE and subjected to immunoblotting wall the ASB proteins can interact with Cul5 and Rbx2, despite
slight divergences from the consensus sequences seen in both
the BC box and the Cul5 box of various SOCS box proteins.
3.3. In vitro E3 Ub ligase activities of ASB complexes containing
Cul5–Rbx2
To determine whether ASB complexes containing Cul5–
Rbx2 function as E3 Ub ligases, we examined their Ub ligase
activities in vitro. The ASB2 complexes were precipitated from
ASB2-Flag-transfected HEK293 cell extracts with anti-Flag
antibody and then mixed with mouse E1 Ub activating enzyme
Uba1, bacterial recombinant E2 Ub conjugating enzyme Ub-
cH5a, GST-Ub and ATP. The mixture was incubated to allow
the ubiquitination reaction to proceed. The reaction products
were electrophoresed on SDS–PAGE, followed by detection
of ubiquitinated proteins with anti-GST antibody. A high-
molecular-weight smear representing GST-Ub-conjugated pro-
teins was observed in the case of the reaction mixture contain-
ing all the above components (Fig. 5A). However, such a smear
was less evident in the absence of E1 and/or E2 and when using
ASB2M1 complexes from HEK293 cells transfected with
ASB2M1, a mutant that did not interact with Cul5–Rbx2.
ASB1 and ASB12 also showed a high-molecular-weight
smear when their complexes obtained from cells transfected
with ASB1 and ASB12 were incubated with E1, E2, GST-Ub
and ATP, although no smears were detected in the absence
of E1 and E2 (Fig. 5B). Thus, it is suggested that ASB com-
plexes containing Cul5–Rbx2 have E3 Ub ligase activity.4. Discussion
The aim of this study was to determine what kinds of Cul–
Rbx modules ASB proteins interact with to form E3 Ub ligase
complexes in vivo. Here, we described two important features.
One is the ﬁnding that ASB proteins associate with Cul5 and
Rbx2 in cells, and the other is that ASB complexes containing
Cul5–Rbx2 express E3 Ub ligase activity.s were transfected with 3 · FLAG-tagged expression vectors expressing
pitated with anti-FLAG antibody. The ASB2- or ASB2M1-complexes
f ATP and GST-Ub. Then the proteins in the reaction mixtures were
antibody. (B) HEK293 cells were transfected with 3 · FLAG-tagged
were prepared and immunoprecipitated with anti-FLAG antibody. The
n the presence of ATP and GST-Ub. Then the proteins in the reaction
ith anti-GST antibody.
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sed ASB2, Elongin B/C, Rbx1 and Cul2 or Cul5, the ASB2-
Elongin B/C complex assembled with the Cul5–Rbx1 module
to form a multiprotein complex having E3 Ub ligase activity
[24]. This result is inconsistent with ours in terms of the com-
bination of Cul and Rbx. Our study clearly showed that ASB
proteins associated with endogenous Cul5–Rbx2 in HEK293
cells, unlike pVHL, which associated with Cul2–Rbx1. SOCS
box proteins that have Cul5 box as well as BC box, such as
SOCS1, SSB1, SSB4 and RAR3, were shown to associate with
Cul5–Rbx2 in vivo in mammalian cells [20]. All the ASB pro-
teins share the consensus sequence of Cul5 box but not Cul2
box. Taken together, it is highly likely that ASB proteins asso-
ciate with the Cul5–Rbx2 but not the Cul5–Rbx1 module in
cells forming E3 Ub ligase complexes, although Rbx2 may
be able to be replaced with Rbx1 in vitro to form a complex
having E3 Ub ligase activity.
In this study, we showed that ASB complexes puriﬁed from
HEK293 cells transfected with some members of the ASB fam-
ily have E3 Ub ligase activity in vitro. Although the ASB com-
plexes were found to contain endogenously expressed Cul5 and
Rbx2, it was not clear whether the substrates are also associated
with those complexes or not. In our preliminary experiments,
when ASB2 complexes puriﬁed from HEK293 cells transfected
with ASB2 were analyzed by SDS–PAGE and proteins were
visualized by silver staining, we could not detect any protein
bands that might be substrates. This implies that the substrate
of ASB2 is not, or only rarely, expressed inHEK293 cells. Alter-
natively, there is a possibility that ASB2-containing E3 Ub li-
gase ubiquitinates ASB2 itself. This is supported by the
ﬁndings that many RING ﬁnger E3 Ub ligases exhibited self-
ubiquitination activity in vitro [25], and that F box proteins
underwent self-ubiquitination in the absence of substrates
[26,27]. However, it remains unclear exactly which proteins
are recognized and ubiquitinated byASBs in cells. Further stud-
ies, including identiﬁcation of the substrates of ASB proteins,
will clarify the molecular mechanisms of ASB–Cul5–Rbx2 E3
Ub ligases and their roles in cellular signal transduction.
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